| Literature DB >> 27273869 |
A J Demetris1, C Bellamy2, S G Hübscher3, J O'Leary4, P S Randhawa1, S Feng5, D Neil6, R B Colvin7, G McCaughan8, J J Fung9, A Del Bello10, F P Reinholt11, H Haga12, O Adeyi13, A J Czaja14, T Schiano15, M I Fiel16, M L Smith17, M Sebagh18, R Y Tanigawa19, F Yilmaz20, G Alexander21, L Baiocchi22, M Balasubramanian23, I Batal24, A K Bhan7, J Bucuvalas25, C T S Cerski26, F Charlotte27, M E de Vera28, M ElMonayeri29, P Fontes1, E E Furth30, A S H Gouw31, S Hafezi-Bakhtiari32, J Hart33, E Honsova34, W Ismail35, T Itoh36, N C Jhala37, U Khettry38, G B Klintmalm4, S Knechtle39, T Koshiba40, T Kozlowski41, C R Lassman42, J Lerut43, J Levitsky44, L Licini45, R Liotta46, G Mazariegos47, M I Minervini1, J Misdraji7, T Mohanakumar48, J Mölne49, I Nasser50, J Neuberger6, M O'Neil51, O Pappo52, L Petrovic53, P Ruiz54, Ö Sağol55, A Sanchez Fueyo56, E Sasatomi57, A Shaked58, M Shiller4, T Shimizu59, B Sis60, A Sonzogni45, H L Stevenson61, S N Thung16, G Tisone62, A C Tsamandas63, A Wernerson64, T Wu65, A Zeevi66, Y Zen36.
Abstract
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5-10, 2011), 12th (Comandatuba, Brazil, August 19-23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5-10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: classification systems: Banff classification; clinical research/practice; guidelines; immunosuppression/immune modulation; liver transplantation/hepatology; rejection: T cell mediated (TCMR); rejection: antibody-mediated (ABMR); tolerance
Mesh：
Substances：
Year: 2016 PMID： 27273869 DOI： 10.1111/ajt.13909
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086